ID 405029295 · FY 2018–2024 · 7 years
Subsidiary of კომანდიტური საზოგადოება დენკ ფარმა (100.0%)
Caucasus regional office of Denk Pharma, a Germany-based generic pharmaceutical manufacturer.
curated 2026-06-03reportal.gedenkpharma.de
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,320 | 11,511 | 19,023 | 20,419 | 16,998 | 20,487 | 22,058 | +31.2% |
| Total COGS | 370 | -6,952 | -10,956 | -12,064 | -10,723 | -11,896 | -12,980 | nmf |
| Gross Profit | 4,690 | 4,559 | 8,067 | 8,354 | 6,275 | 8,591 | 9,078 | +11.6% |
| Gross Margin | 108.6% | 39.6% | 42.4% | 40.9% | 36.9% | 41.9% | 41.2% | |
| Total Operating Expenses | -3,431 | -3,727 | -5,469 | -6,461 | -6,539 | -7,758 | -6,715 | +11.8% |
| EBITDA | 1,259 | 832 | 2,598 | 1,893 | -264 | 833 | 2,363 | +11.1% |
| EBITDA Margin | 29.2% | 7.2% | 13.7% | 9.3% | -1.6% | 4.1% | 10.7% | |
| Total D&A | -46 | -75 | -109 | -163 | -188 | -236 | -267 | +33.8% |
| EBIT / Operating Income | 1,213 | 757 | 2,489 | 1,730 | -452 | 597 | 2,096 | +9.5% |
| Total Interest Income | 0 | 0 | 0 | 3 | 54 | 47 | 0 | +329.7% |
| Total Other Income | -84 | -315 | -830 | 453 | 646 | -219 | -423 | +31.0% |
| Profit Before Tax | 1,129 | 442 | 1,659 | 2,185 | 248 | 426 | 1,673 | +6.8% |
| Total Income Tax | 0 | 0 | 0 | -314 | 0 | 0 | -265 | -5.5% |
| Net Profit / (Loss) | 806 | 517 | 1,756 | 1,719 | 242 | 589 | 1,408 | +9.7% |
| Net Margin | 18.7% | 4.5% | 9.2% | 8.4% | 1.4% | 2.9% | 6.4% |
Ownership & directors from companyinfo.ge (public corporate registry).